An excellent therapeutic response to biologics indicates a pivotal pathogenic role of interleukin (IL)-4/IL-13 signaling in AD [16,17] and the tumor necrosis factor (TNF)-α/IL-23/IL-17A axis in psoriasis [18,19]. Here, IL13 is linked to psoriasis.